Association of GBA genotype with motor and cognitive decline in Chinese Parkinson’s disease patients
Authors:
Open Access
- 10 February 2023
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Aging Neuroscience
- Vol. 15, 1091919
Abstract
Objective: Variants in the glucocerebrosidase (GBA) gene are the most common and significant risk factor for Parkinson’s disease (PD). However, the impact ofGBAvariants on PD disease progression in the Chinese population remains unclear. This study aimed to explore the significance ofGBAstatus on motor and cognitive impairment in a longitudinal cohort of Chinese patients with PD.Methods: The entireGBAgene was screened by long-range polymerase chain reaction (LR-PCR) and next generation sequencing (NGS). A total of 43GBA-related PD (GBA-PD) and 246 non-GBA-mutated PD (NM-PD) patients with complete clinical data at baseline and at least one follow-up were recruited for this study. The associations ofGBAgenotype with rate of motor and cognitive decline, as measured by Unified PD Rating Scale (UPDRS) motor and Montreal Cognitive Assessment (MoCA), were assessed by linear mixed-effect models.Results: The estimated (standard error, SE) UPDRS motor [2.25 (0.38) points/year] and MoCA [−0.53 (0.11) points/year] progression rates in theGBA-PD group were significantly faster than those in the NM-PD group [1.35 (0.19); −0.29 (0.04) points/year; respectively]. In addition, theGBA-PD group showed significantly faster estimated (SE) bradykinesia [1.04 (0.18) points/year], axial impairment [0.38 (0.07) points/year], and visuospatial/executive [−0.15 (0.03) points/year] progression rates than the NM-PD group [0.62 (0.10); 0.17 (0.04); −0.07 (0.01) points/year; respectively].Conclusion: GBA-PD is associated with faster motor and cognitive decline, specifically greater disability in terms of bradykinesia, axial impairment, and visuospatial/executive function. Better understanding ofGBA-PD progression may help predict prognosis and improve clinical trial design.Keywords
This publication has 40 references indexed in Scilit:
- Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelinesMovement Disorders, 2012
- Systematic review of levodopa dose equivalency reporting in Parkinson's diseaseMovement Disorders, 2010
- Association between GBA L444P mutation and sporadic Parkinson's disease from Mainland ChinaNeuroscience Letters, 2010
- Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson diseaseNeurology, 2009
- Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's DiseaseNew England Journal of Medicine, 2009
- Glucocerebrosidase mutations in clinical and pathologically proven Parkinson's diseaseBrain, 2009
- Gaucher disease: mutation and polymorphism spectrum in the glucocerebrosidase gene (GBA)Human Mutation, 2008
- The Montreal Cognitive Assessment, MoCA: A Brief Screening Tool For Mild Cognitive ImpairmentJournal of the American Geriatrics Society, 2005
- The human glucocerebrosidase gene and pseudogene: Structure and evolutionGenomics, 1989
- The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease.Journal of Neurology, Neurosurgery & Psychiatry, 1988